Article(id=1329527491280089735, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527450167521545, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.12.009, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1711555200000, receivedDateStr=2024-03-28, revisedDate=1720713600000, revisedDateStr=2024-07-12, acceptedDate=null, acceptedDateStr=null, onlineDate=1794913655347, onlineDateStr=2026-11-17, pubDate=1733760000000, pubDateStr=2024-12-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794913655347, onlineIssueDateStr=2026-11-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794913655347, creator=13701087609, updateTime=1794913655347, updator=13701087609, issue=Issue{id=1329527450167521545, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='12', pageStart='1213', pageEnd='1322', issueExtLink='null', onlineDate='null', pubDate='1733760000000', pubDateStr='2024-12-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794913645544, creator='13701087609', updateTime=1794962240721, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329731273578361214, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527450167521545, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329731273578361215, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527450167521545, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1269, endPage=1275, ext={EN=ArticleExt(id=1329527491452056200, articleId=1329527491280089735, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Application of vericiguat combined with dapagliflozin in patients with heart failure with reduced ejection fraction, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective

To observe the effect of vericiguat combined with dapagliflozin in patients with heart failure with reduced ejection fraction (HFrEF).

Methods

A total of 98 patients with HFrEF in our hospital from January 2023 to January 2024 were selected and divided into combination group and control group according to random number table method, with 49 cases in each group. On the basis of conventional HF treatment, the control group was given dapagliflozin, the combination group was given dapagliflozin combined with vericiguat. Both groups were treated for 6 months. The clinical effect, adverse reactions, HF rehospitalization rate and major adverse cardiovascular event (MACE) were compared between the two groups. The cardiac function indexes, N-terminal brain natriuretic peptide precursor (NT-proBNP), neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP), Minnesota living with heart failure questionnaire (MLHFQ) score, 6-minute walking test (6MWT) distance were compared between the two groups before and after treatment.

Results

After treatment, the total effective rate of combination group was higher than that of control group (93.62% vs 70.83%, P<0.05). The LVEF level and 6MWT distance were increased in both groups, and the combination group was higher than the control group (P<0.05). The levels of LVEDD, LVESD, NT-proBNP, NLR, CRP and MLHFQ score were all decreased, and the combination group was lower than the control group (P<0.05). There was no significant difference in the occurrence of adverse reactions between the two groups (P<0.05). The incidence of HF rehospitalization (6.38% vs 20.83%, P<0.05) and MACE (12.77% vs 31.25%, P<0.05) in the combination group were lower than those in the control group, respectively.

Conclusion

Vericiguat combined with dapagliflozin can significantly reduce ventricular remodeling and inflammatory response in HFrEF patients, enhance efficacy, improve quality of life and prognosis, and have good safety.

, authors=Aifen LU, Guijia ZHU, Zhikuan FENG, Junyou LIU, Ke ZHANG, authorsList=Aifen LU, Guijia ZHU, Zhikuan FENG, Junyou LIU, Ke ZHANG, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329527491661771401, articleId=1329527491280089735, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=维立西呱联合达格列净在射血分数减低型心力衰竭患者中的应用观察, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的

观察维立西呱联合达格列净在射血分数减低型心力衰竭(heart failure with reduced ejection fraction,HFrEF)中的应用效果。

方法

选择2023年1月至2024年1月我院HFrEF患者98例,按随机数字表法分为联合组和对照组,每组49例。在常规HF治疗基础上,予对照组达格列净,予联合组达格列净联合维立西呱,两组均治疗6个月。比较两组临床效果、不良反应、HF再住院率、主要不良心血管事件(major adverse cardiovascular event,MACE)发生率与治疗前后心功能指标、N-末端脑钠肽前体(N-terminal brain natriuretic peptide precursor,NT-proBNP)、中性粒细胞与淋巴细胞比值(neutrophil-to-lymphocyte ratio,NLR)、C反应蛋白(C-reactive protein,CRP)、明尼苏达心力衰竭生活质量量表(Minnesota living with heart failure questionnaire,MLHFQ)评分、6 min步行试验(6-minute walking test,6MWT)距离。

结果

治疗后,联合组总有效率高于对照组(93.62% vs 70.83%,P<0.05)。两组LVEF水平、6MWT距离均升高,且联合组高于对照组(P<0.05)。LVEDD、LVESD、NT-proBNP、NLR、CRP水平及MLHFQ评分均降低,且联合组低于对照组(P<0.05)。两组不良反应发生情况无显著差异(P<0.05)。在HF再住院(6.38% vs 20.83%,P<0.05)、MACE发生率(12.77% vs 31.25%,P<0.05)方面,联合组均分别低于对照组。

结论

维立西呱联合达格列净可显著减轻HFrEF患者心室重构与炎症反应,增强疗效,改善生活质量及预后,且安全性佳。

, authors=鲁爱粉, 朱贵家, 冯治宽, 刘军友, 张可, authorsList=鲁爱粉, 朱贵家, 冯治宽, 刘军友, 张可, authorCompany=null, correspAuthors=null, authorNote=

鲁爱粉,硕士研究生,副主任医师,研究方向:冠心病及心脏急危重症。

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=vcdqD/p4ApXtiQOqT3zK7A==, magXml=zXOMWMqcCc7Csz3dMux1qQ==, pdfUrl=null, pdf=aXZoAONDjeaN5IeLJZfz5Q==, pdfFileSize=1618928, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=GwPSbIPoPZPyug8GBB20Gg==, mapNumber=null, fund=null)}, authors=[Author(id=1329527491942789774, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527492014092944, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527491942789774, language=EN, stringName=Aifen LU, firstName=Aifen, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527492097979025, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527491942789774, language=CN, stringName=鲁爱粉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=濮阳市油田总医院心内科,河南 濮阳 457001, bio={"content":"

鲁爱粉,硕士研究生,副主任医师,研究方向:冠心病及心脏急危重症。

"}, bioImg=null, bioContent=

鲁爱粉,硕士研究生,副主任医师,研究方向:冠心病及心脏急危重症。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527491858903690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, xref=null, ext=[AuthorCompanyExt(id=1329527491875680907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China), AuthorCompanyExt(id=1329527491888263820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=濮阳市油田总医院心内科,河南 濮阳 457001)])]), Author(id=1329527492165087891, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527492253168277, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492165087891, language=EN, stringName=Guijia ZHU, firstName=Guijia, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527492316082838, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492165087891, language=CN, stringName=朱贵家, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=濮阳市油田总医院心内科,河南 濮阳 457001, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527491858903690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, xref=null, ext=[AuthorCompanyExt(id=1329527491875680907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China), AuthorCompanyExt(id=1329527491888263820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=濮阳市油田总医院心内科,河南 濮阳 457001)])]), Author(id=1329527492391580312, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527492454494874, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492391580312, language=EN, stringName=Zhikuan FENG, firstName=Zhikuan, middleName=null, lastName=FENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527492517409435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492391580312, language=CN, stringName=冯治宽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=濮阳市油田总医院心内科,河南 濮阳 457001, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527491858903690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, xref=null, ext=[AuthorCompanyExt(id=1329527491875680907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China), AuthorCompanyExt(id=1329527491888263820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=濮阳市油田总医院心内科,河南 濮阳 457001)])]), Author(id=1329527492571935389, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527492655821471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492571935389, language=EN, stringName=Junyou LIU, firstName=Junyou, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527492743901856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492571935389, language=CN, stringName=刘军友, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=濮阳市油田总医院心内科,河南 濮阳 457001, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527491858903690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, xref=null, ext=[AuthorCompanyExt(id=1329527491875680907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China), AuthorCompanyExt(id=1329527491888263820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=濮阳市油田总医院心内科,河南 濮阳 457001)])]), Author(id=1329527492819399330, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527492932645540, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492819399330, language=EN, stringName=Ke ZHANG, firstName=Ke, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527492995560101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492819399330, language=CN, stringName=张可, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=濮阳市油田总医院心内科,河南 濮阳 457001, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527491858903690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, xref=null, ext=[AuthorCompanyExt(id=1329527491875680907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China), AuthorCompanyExt(id=1329527491888263820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=濮阳市油田总医院心内科,河南 濮阳 457001)])])], keywords=[Keyword(id=1329527493100417702, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, language=EN, orderNo=1, keyword=vericiguat), Keyword(id=1329527494698447527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, language=EN, orderNo=2, keyword=dapagliflozin), Keyword(id=1329527494782333608, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, language=EN, orderNo=3, keyword=heart failure with reduced ejection fraction), Keyword(id=1329527494845248169, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, language=EN, orderNo=4, keyword=ventricular remodeling), Keyword(id=1329527494908162730, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, language=CN, orderNo=1, keyword=维立西呱), Keyword(id=1329527494979465899, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, language=CN, orderNo=2, keyword=达格列净), Keyword(id=1329527495038186156, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, language=CN, orderNo=3, keyword=射血分数减低型心力衰竭), Keyword(id=1329527495105295021, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, language=CN, orderNo=4, keyword=心室重构)], refs=[Reference(id=1329527495197569710, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Yan T, Zhu S, Yin X, et al. Burden, trends, and inequalities of heart failure globally, 1990 to 2019: a secondary analysis based on the global burden of disease 2019 study[J]. J Am Heart Assoc, 2023, 12(6): e027852., articleTitle=null, refAbstract=null), Reference(id=1329527495281455791, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Kondo T, Jhund PS, McMurray JJV. Drug therapy for heart failure with reduced ejection fraction: what is the 'right' dose[J]. Eur J Heart Fail, 2022, 24(3): 421-430., articleTitle=null, refAbstract=null), Reference(id=1329527495390507696, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Lam CSP, Giczewska A, Sliwa K, et al. Clinical outcomes and response to vericiguat according to index heart failure event: insights from the VICTORIA trial[J]. J Am Med Assoc Cardiol, 2021, 6(6): 706-712., articleTitle=null, refAbstract=null), Reference(id=1329527495482782385, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Vardeny O, Fang JC, Desai AS, et al. Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial[J]. Nat Med, 2022, 28(12): 2504-2511., articleTitle=null, refAbstract=null), Reference(id=1329527495562474162, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Solomon SD, McMurray JJV, Claggett B, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction[J]. N Engl J Med, 2022, 387(12): 1089-1098., articleTitle=null, refAbstract=null), Reference(id=1329527495637971635, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=卢谦, 邓艺敏, 杨宗旺, 等. 达格列净对射血分数下降型心力衰竭不伴2型糖尿病患者心肌做功和能量代谢影响[J]. 中国药师, 2024, 27(1): 100-108., articleTitle=null, refAbstract=null), Reference(id=1329527495713469108, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Emdin M, Aimo A, Castiglione V. Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it is[J]. Eur J Heart Fail, 2022, 24(5): 791-793., articleTitle=null, refAbstract=null), Reference(id=1329527495788966581, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Senni M, Alemayehu WG, Sim D, et al. Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial[J]. Eur J Heart Fail, 2022, 24(9): 1614-1622., articleTitle=null, refAbstract=null), Reference(id=1329527495872852662, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Xia J, Hui N, Tian L, et al. Development of vericiguat: the first soluble guanylate cyclase (sGC) stimulator launched for heart failure with reduced ejection fraction (HFrEF)[J]. Biomed Pharmacother, 2022, 149: 112894., articleTitle=null, refAbstract=null), Reference(id=1329527495948350135, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760-789., articleTitle=null, refAbstract=null), Reference(id=1329527496011264696, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=肖勇强, 黄纪卫. 达格列净联合左西孟旦治疗老年射血分数减低型心力衰竭患者的效果[J]. 世界临床药物, 2023, 44(5): 477-482., articleTitle=null, refAbstract=null), Reference(id=1329527496099345081, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Berliner D, Hanselmann A, Bauersachs J. The treatment of heart failure with reduced ejection fraction[J]. Dtsch Arztebl Int, 2020, 117(21): 376-386., articleTitle=null, refAbstract=null), Reference(id=1329527496183231162, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Aziz H, Gouda P, Sharma A. Vericiguat in the management of heart failure with reduced ejection fraction[J]. Eur Heart J Cardiovasc Pharmacother, 2021, 7(4): e65-e66., articleTitle=null, refAbstract=null), Reference(id=1329527496262922939, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Lombardi CM, Cimino G, Pagnesi M, et al. Vericiguat for heart failure with reduced ejection fraction[J]. Curr Cardiol Rep, 2021, 23(10): 144., articleTitle=null, refAbstract=null), Reference(id=1329527496325837500, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction[J]. N Engl J Med, 2019, 381(21): 1995-2008., articleTitle=null, refAbstract=null), Reference(id=1329527496388752061, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Kosiborod MN, Jhund PS, Docherty KF, et al. Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial[J]. Circulation, 2020, 141(2): 90-99., articleTitle=null, refAbstract=null), Reference(id=1329527496481026750, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Berg DD, Jhund PS, Docherty KF, et al. Time to clinical benefit of dapagliflozin and significance of prior heart failure hospitalization in patients with heart failure with reduced ejection fraction[J]. J Am Med Assoc Cardiol, 2021, 6(5): 499-507., articleTitle=null, refAbstract=null), Reference(id=1329527496581690047, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Inzucchi SE, Claggett BL, Vaduganathan M, et al. Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial[J]. Lancet Diabetes Endocrinol, 2022, 10(12): 869-881., articleTitle=null, refAbstract=null), Reference(id=1329527496657187520, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Martinez FA, Serenelli M, Nicolau JC, et al. Efficacy and safety of dapagliflozin in heart failure with reduced ejection fraction according to age: insights from DAPA-HF[J]. Circulation, 2020, 141(2): 100-111., articleTitle=null, refAbstract=null), Reference(id=1329527496728490689, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=McMurray JJV, DeMets DL, Inzucchi SE, et al. A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)[J]. Eur J Heart Fail, 2019, 21(5): 665-675., articleTitle=null, refAbstract=null), Reference(id=1329527496799793858, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Petrie MC, Verma S, Docherty KF, et al. Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes[J]. J Am Med Assoc, 2020, 323(14): 1353-1368., articleTitle=null, refAbstract=null), Reference(id=1329527496862708419, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Nassif ME, Windsor SL, Tang F, et al. Dapagliflozin effects on biomarkers, symptoms, and functional status in patients with heart failure with reduced ejection fraction: the DEFINE-HF trial[J]. Circulation, 2019, 140(18): 1463-1476., articleTitle=null, refAbstract=null), Reference(id=1329527496946594500, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Ryan JJ, Maron BA. Vericiguat in heart failure with reduced ejection fraction[J]. N Engl J Med, 2020, 383(15): 1497., articleTitle=null, refAbstract=null), Reference(id=1329527497013703365, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Wearden J, Hough A, Kaiser S. Vericiguat in heart failure with reduced ejection fraction[J]. N Engl J Med, 2020, 383(15): 1496-1497., articleTitle=null, refAbstract=null), Reference(id=1329527497080812230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Saldarriaga C, Atar D, Stebbins A, et al. Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction[J]. Eur J Heart Fail, 2022, 24(5): 782-790., articleTitle=null, refAbstract=null), Reference(id=1329527497164698311, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Butler J, Usman MS, Anstrom KJ, et al. Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum[J]. Eur J Heart Fail, 2022, 24(11): 2029-2036., articleTitle=null, refAbstract=null), Reference(id=1329527497236001480, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Armstrong PW, Pieske B, Anstrom KJ, et al. Vericiguat in patients with heart failure and reduced ejection fraction[J]. N Engl J Med, 2020, 382(20): 1883-1893., articleTitle=null, refAbstract=null), Reference(id=1329527497319887561, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Chew DS, Li Y, Bigelow R, et al. Cost-effectiveness of vericiguat in patients with heart failure with reduced ejection fraction: the VICTORIA randomized clinical trial[J]. Circulation, 2023, 148(14): 1087-1098., articleTitle=null, refAbstract=null), Reference(id=1329527497412162250, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Ezekowitz JA, O'Connor CM, Troughton RW, et al. N-terminal pro-B-type natriuretic peptide and clinical outcomes: vericiguat heart failure with reduced ejection fraction study[J]. JACC Heart Fail, 2020, 8(11): 931-939., articleTitle=null, refAbstract=null), Reference(id=1329527497487659723, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=王建丽, 周琳, 肖小玲, 等. 沙库巴曲缬沙坦联合达格列净对射血分数减低型心衰不伴糖尿病患者的疗效[J]. 西安交通大学学报(医学版), 2023, 44(3): 415-420., articleTitle=null, refAbstract=null), Reference(id=1329527497554768588, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=甄根深, 张奇峰, 刘威, 等. hs-cTnI及NT-proBNP最佳截断值与慢性心衰患者生存期的相关性研究[J]. 中国循证心血管医学杂志, 2019, 11(4): 484-486., articleTitle=null, refAbstract=null), Reference(id=1329527499165381325, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=刘海燕, 宋毓青, 陈永福, 等. 沙库巴曲缬沙坦对射血分数降低型慢性心力衰竭患者的临床疗效及对B型脑钠肽和C反应蛋白水平的影响[J]. 中国医药, 2022, 17(1): 15-18., articleTitle=null, refAbstract=null), Reference(id=1329527499236684494, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang Z, Li G, Huang R, et al. Prognostic value of fibrosis-5 index combined with C-reactive protein in patients with acute decompensated heart failure[J]. Bio Med Central Cardiovasc Disord, 2023, 23(1): 492., articleTitle=null, refAbstract=null), Reference(id=1329527499303793359, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Verma R, Moroney M, Hibino M, et al. Baseline neutrophil-to-lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodelling[J]. ESC Heart Fail, 2023, 10(3): 2127-2133., articleTitle=null, refAbstract=null), Reference(id=1329527499362513616, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Garcia-Escobar A, Vera-Vera S, Tebar-Marquez D, et al. Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: new insights for a potential predictor of anti-cytokine therapy responsiveness[J]. Microvasc Res, 2023, 150: 104598., articleTitle=null, refAbstract=null), Reference(id=1329527499433816785, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=杨攀, 张琼, 王学影. 达格列净治疗射血分数降低心衰患者的疗效观察[J]. 广西医科大学学报, 2021, 38(7): 1436-1441., articleTitle=null, refAbstract=null), Reference(id=1329527499500925650, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Kramer F, Voss S, Roessig L, et al. Evaluation of high-sensitivity C-reactive protein and uric acid in vericiguat-treated patients with heart failure with reduced ejection fraction[J]. Eur J Heart Fail, 2020, 22(9): 1675-1683., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329527491858903690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, xref=null, ext=[AuthorCompanyExt(id=1329527491875680907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China), AuthorCompanyExt(id=1329527491888263820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=濮阳市油田总医院心内科,河南 濮阳 457001)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.12.009, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.12.009, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.12.009, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.12.009, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1733760000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
维立西呱联合达格列净在射血分数减低型心力衰竭患者中的应用观察
鲁爱粉 , 朱贵家 , 冯治宽 , 刘军友 , 张可
世界临床药物 | 研究论文 2024,45(12): 1269-1275
收起
收藏切换
世界临床药物 |研究论文 2024 , 45 (12) : 1269 -1275
维立西呱联合达格列净在射血分数减低型心力衰竭患者中的应用观察
全屏
[Author(id=1329527491942789774, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527492014092944, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527491942789774, language=EN, stringName=Aifen LU, firstName=Aifen, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527492097979025, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527491942789774, language=CN, stringName=鲁爱粉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=濮阳市油田总医院心内科,河南 濮阳 457001, bio={"content":"

鲁爱粉,硕士研究生,副主任医师,研究方向:冠心病及心脏急危重症。

"}, bioImg=null, bioContent=

鲁爱粉,硕士研究生,副主任医师,研究方向:冠心病及心脏急危重症。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527491858903690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, xref=null, ext=[AuthorCompanyExt(id=1329527491875680907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China), AuthorCompanyExt(id=1329527491888263820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=濮阳市油田总医院心内科,河南 濮阳 457001)])]), Author(id=1329527492165087891, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527492253168277, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492165087891, language=EN, stringName=Guijia ZHU, firstName=Guijia, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527492316082838, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492165087891, language=CN, stringName=朱贵家, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=濮阳市油田总医院心内科,河南 濮阳 457001, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527491858903690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, xref=null, ext=[AuthorCompanyExt(id=1329527491875680907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China), AuthorCompanyExt(id=1329527491888263820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=濮阳市油田总医院心内科,河南 濮阳 457001)])]), Author(id=1329527492391580312, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527492454494874, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492391580312, language=EN, stringName=Zhikuan FENG, firstName=Zhikuan, middleName=null, lastName=FENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527492517409435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492391580312, language=CN, stringName=冯治宽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=濮阳市油田总医院心内科,河南 濮阳 457001, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527491858903690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, xref=null, ext=[AuthorCompanyExt(id=1329527491875680907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China), AuthorCompanyExt(id=1329527491888263820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=濮阳市油田总医院心内科,河南 濮阳 457001)])]), Author(id=1329527492571935389, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527492655821471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492571935389, language=EN, stringName=Junyou LIU, firstName=Junyou, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527492743901856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492571935389, language=CN, stringName=刘军友, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=濮阳市油田总医院心内科,河南 濮阳 457001, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527491858903690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, xref=null, ext=[AuthorCompanyExt(id=1329527491875680907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China), AuthorCompanyExt(id=1329527491888263820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=濮阳市油田总医院心内科,河南 濮阳 457001)])]), Author(id=1329527492819399330, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527492932645540, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492819399330, language=EN, stringName=Ke ZHANG, firstName=Ke, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527492995560101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, authorId=1329527492819399330, language=CN, stringName=张可, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=濮阳市油田总医院心内科,河南 濮阳 457001, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527491858903690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, xref=null, ext=[AuthorCompanyExt(id=1329527491875680907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China), AuthorCompanyExt(id=1329527491888263820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527491280089735, companyId=1329527491858903690, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=濮阳市油田总医院心内科,河南 濮阳 457001)])])]
鲁爱粉, 朱贵家, 冯治宽, 刘军友, 张可
作者信息
  • 濮阳市油田总医院心内科,河南 濮阳 457001
作者简介:

鲁爱粉,硕士研究生,副主任医师,研究方向:冠心病及心脏急危重症。

Application of vericiguat combined with dapagliflozin in patients with heart failure with reduced ejection fraction
Aifen LU, Guijia ZHU, Zhikuan FENG, Junyou LIU, Ke ZHANG
Affiliations
  • Department of Cardiology, Puyang Oilfield General Hospital, Puyang 457001, Henan Province, China
出版时间: 2024-12-10 doi: 10.13683/j.wph.2024.12.009
文章导航
收藏切换
目的

观察维立西呱联合达格列净在射血分数减低型心力衰竭(heart failure with reduced ejection fraction,HFrEF)中的应用效果。

方法

选择2023年1月至2024年1月我院HFrEF患者98例,按随机数字表法分为联合组和对照组,每组49例。在常规HF治疗基础上,予对照组达格列净,予联合组达格列净联合维立西呱,两组均治疗6个月。比较两组临床效果、不良反应、HF再住院率、主要不良心血管事件(major adverse cardiovascular event,MACE)发生率与治疗前后心功能指标、N-末端脑钠肽前体(N-terminal brain natriuretic peptide precursor,NT-proBNP)、中性粒细胞与淋巴细胞比值(neutrophil-to-lymphocyte ratio,NLR)、C反应蛋白(C-reactive protein,CRP)、明尼苏达心力衰竭生活质量量表(Minnesota living with heart failure questionnaire,MLHFQ)评分、6 min步行试验(6-minute walking test,6MWT)距离。

结果

治疗后,联合组总有效率高于对照组(93.62% vs 70.83%,P<0.05)。两组LVEF水平、6MWT距离均升高,且联合组高于对照组(P<0.05)。LVEDD、LVESD、NT-proBNP、NLR、CRP水平及MLHFQ评分均降低,且联合组低于对照组(P<0.05)。两组不良反应发生情况无显著差异(P<0.05)。在HF再住院(6.38% vs 20.83%,P<0.05)、MACE发生率(12.77% vs 31.25%,P<0.05)方面,联合组均分别低于对照组。

结论

维立西呱联合达格列净可显著减轻HFrEF患者心室重构与炎症反应,增强疗效,改善生活质量及预后,且安全性佳。

维立西呱  /  达格列净  /  射血分数减低型心力衰竭  /  心室重构
Objective

To observe the effect of vericiguat combined with dapagliflozin in patients with heart failure with reduced ejection fraction (HFrEF).

Methods

A total of 98 patients with HFrEF in our hospital from January 2023 to January 2024 were selected and divided into combination group and control group according to random number table method, with 49 cases in each group. On the basis of conventional HF treatment, the control group was given dapagliflozin, the combination group was given dapagliflozin combined with vericiguat. Both groups were treated for 6 months. The clinical effect, adverse reactions, HF rehospitalization rate and major adverse cardiovascular event (MACE) were compared between the two groups. The cardiac function indexes, N-terminal brain natriuretic peptide precursor (NT-proBNP), neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP), Minnesota living with heart failure questionnaire (MLHFQ) score, 6-minute walking test (6MWT) distance were compared between the two groups before and after treatment.

Results

After treatment, the total effective rate of combination group was higher than that of control group (93.62% vs 70.83%, P<0.05). The LVEF level and 6MWT distance were increased in both groups, and the combination group was higher than the control group (P<0.05). The levels of LVEDD, LVESD, NT-proBNP, NLR, CRP and MLHFQ score were all decreased, and the combination group was lower than the control group (P<0.05). There was no significant difference in the occurrence of adverse reactions between the two groups (P<0.05). The incidence of HF rehospitalization (6.38% vs 20.83%, P<0.05) and MACE (12.77% vs 31.25%, P<0.05) in the combination group were lower than those in the control group, respectively.

Conclusion

Vericiguat combined with dapagliflozin can significantly reduce ventricular remodeling and inflammatory response in HFrEF patients, enhance efficacy, improve quality of life and prognosis, and have good safety.

vericiguat  /  dapagliflozin  /  heart failure with reduced ejection fraction  /  ventricular remodeling
鲁爱粉, 朱贵家, 冯治宽, 刘军友, 张可. 维立西呱联合达格列净在射血分数减低型心力衰竭患者中的应用观察. 世界临床药物, 2024 , 45 (12) : 1269 -1275 . DOI: 10.13683/j.wph.2024.12.009
Aifen LU, Guijia ZHU, Zhikuan FENG, Junyou LIU, Ke ZHANG. Application of vericiguat combined with dapagliflozin in patients with heart failure with reduced ejection fraction[J]. World Clinical Drug, 2024 , 45 (12) : 1269 -1275 . DOI: 10.13683/j.wph.2024.12.009

参考文献 引证文献
排序方式:
[1]
Yan T, Zhu S, Yin X, et al. Burden, trends, and inequalities of heart failure globally, 1990 to 2019: a secondary analysis based on the global burden of disease 2019 study[J]. J Am Heart Assoc, 2023, 12(6): e027852.
[2]
Kondo T, Jhund PS, McMurray JJV. Drug therapy for heart failure with reduced ejection fraction: what is the 'right' dose[J]. Eur J Heart Fail, 2022, 24(3): 421-430.
[3]
Lam CSP, Giczewska A, Sliwa K, et al. Clinical outcomes and response to vericiguat according to index heart failure event: insights from the VICTORIA trial[J]. J Am Med Assoc Cardiol, 2021, 6(6): 706-712.
[4]
Vardeny O, Fang JC, Desai AS, et al. Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial[J]. Nat Med, 2022, 28(12): 2504-2511.
[5]
Solomon SD, McMurray JJV, Claggett B, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction[J]. N Engl J Med, 2022, 387(12): 1089-1098.
[6]
卢谦, 邓艺敏, 杨宗旺, 等. 达格列净对射血分数下降型心力衰竭不伴2型糖尿病患者心肌做功和能量代谢影响[J]. 中国药师, 2024, 27(1): 100-108.
[7]
Emdin M, Aimo A, Castiglione V. Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it is[J]. Eur J Heart Fail, 2022, 24(5): 791-793.
[8]
Senni M, Alemayehu WG, Sim D, et al. Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial[J]. Eur J Heart Fail, 2022, 24(9): 1614-1622.
[9]
Xia J, Hui N, Tian L, et al. Development of vericiguat: the first soluble guanylate cyclase (sGC) stimulator launched for heart failure with reduced ejection fraction (HFrEF)[J]. Biomed Pharmacother, 2022, 149: 112894.
[10]
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760-789.
[11]
肖勇强, 黄纪卫. 达格列净联合左西孟旦治疗老年射血分数减低型心力衰竭患者的效果[J]. 世界临床药物, 2023, 44(5): 477-482.
[12]
Berliner D, Hanselmann A, Bauersachs J. The treatment of heart failure with reduced ejection fraction[J]. Dtsch Arztebl Int, 2020, 117(21): 376-386.
[13]
Aziz H, Gouda P, Sharma A. Vericiguat in the management of heart failure with reduced ejection fraction[J]. Eur Heart J Cardiovasc Pharmacother, 2021, 7(4): e65-e66.
[14]
Lombardi CM, Cimino G, Pagnesi M, et al. Vericiguat for heart failure with reduced ejection fraction[J]. Curr Cardiol Rep, 2021, 23(10): 144.
[15]
McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction[J]. N Engl J Med, 2019, 381(21): 1995-2008.
[16]
Kosiborod MN, Jhund PS, Docherty KF, et al. Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial[J]. Circulation, 2020, 141(2): 90-99.
[17]
Berg DD, Jhund PS, Docherty KF, et al. Time to clinical benefit of dapagliflozin and significance of prior heart failure hospitalization in patients with heart failure with reduced ejection fraction[J]. J Am Med Assoc Cardiol, 2021, 6(5): 499-507.
[18]
Inzucchi SE, Claggett BL, Vaduganathan M, et al. Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial[J]. Lancet Diabetes Endocrinol, 2022, 10(12): 869-881.
[19]
Martinez FA, Serenelli M, Nicolau JC, et al. Efficacy and safety of dapagliflozin in heart failure with reduced ejection fraction according to age: insights from DAPA-HF[J]. Circulation, 2020, 141(2): 100-111.
[20]
McMurray JJV, DeMets DL, Inzucchi SE, et al. A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)[J]. Eur J Heart Fail, 2019, 21(5): 665-675.
[21]
Petrie MC, Verma S, Docherty KF, et al. Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes[J]. J Am Med Assoc, 2020, 323(14): 1353-1368.
[22]
Nassif ME, Windsor SL, Tang F, et al. Dapagliflozin effects on biomarkers, symptoms, and functional status in patients with heart failure with reduced ejection fraction: the DEFINE-HF trial[J]. Circulation, 2019, 140(18): 1463-1476.
[23]
Ryan JJ, Maron BA. Vericiguat in heart failure with reduced ejection fraction[J]. N Engl J Med, 2020, 383(15): 1497.
[24]
Wearden J, Hough A, Kaiser S. Vericiguat in heart failure with reduced ejection fraction[J]. N Engl J Med, 2020, 383(15): 1496-1497.
[25]
Saldarriaga C, Atar D, Stebbins A, et al. Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction[J]. Eur J Heart Fail, 2022, 24(5): 782-790.
[26]
Butler J, Usman MS, Anstrom KJ, et al. Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum[J]. Eur J Heart Fail, 2022, 24(11): 2029-2036.
[27]
Armstrong PW, Pieske B, Anstrom KJ, et al. Vericiguat in patients with heart failure and reduced ejection fraction[J]. N Engl J Med, 2020, 382(20): 1883-1893.
[28]
Chew DS, Li Y, Bigelow R, et al. Cost-effectiveness of vericiguat in patients with heart failure with reduced ejection fraction: the VICTORIA randomized clinical trial[J]. Circulation, 2023, 148(14): 1087-1098.
[29]
Ezekowitz JA, O'Connor CM, Troughton RW, et al. N-terminal pro-B-type natriuretic peptide and clinical outcomes: vericiguat heart failure with reduced ejection fraction study[J]. JACC Heart Fail, 2020, 8(11): 931-939.
[30]
王建丽, 周琳, 肖小玲, 等. 沙库巴曲缬沙坦联合达格列净对射血分数减低型心衰不伴糖尿病患者的疗效[J]. 西安交通大学学报(医学版), 2023, 44(3): 415-420.
[31]
甄根深, 张奇峰, 刘威, 等. hs-cTnI及NT-proBNP最佳截断值与慢性心衰患者生存期的相关性研究[J]. 中国循证心血管医学杂志, 2019, 11(4): 484-486.
[32]
刘海燕, 宋毓青, 陈永福, 等. 沙库巴曲缬沙坦对射血分数降低型慢性心力衰竭患者的临床疗效及对B型脑钠肽和C反应蛋白水平的影响[J]. 中国医药, 2022, 17(1): 15-18.
[33]
Wang Z, Li G, Huang R, et al. Prognostic value of fibrosis-5 index combined with C-reactive protein in patients with acute decompensated heart failure[J]. Bio Med Central Cardiovasc Disord, 2023, 23(1): 492.
[34]
Verma R, Moroney M, Hibino M, et al. Baseline neutrophil-to-lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodelling[J]. ESC Heart Fail, 2023, 10(3): 2127-2133.
[35]
Garcia-Escobar A, Vera-Vera S, Tebar-Marquez D, et al. Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: new insights for a potential predictor of anti-cytokine therapy responsiveness[J]. Microvasc Res, 2023, 150: 104598.
[36]
杨攀, 张琼, 王学影. 达格列净治疗射血分数降低心衰患者的疗效观察[J]. 广西医科大学学报, 2021, 38(7): 1436-1441.
[37]
Kramer F, Voss S, Roessig L, et al. Evaluation of high-sensitivity C-reactive protein and uric acid in vericiguat-treated patients with heart failure with reduced ejection fraction[J]. Eur J Heart Fail, 2020, 22(9): 1675-1683.
2024年第45卷第12期
22
0
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.12.009
  • 接收时间:2024-03-28
  • 首发时间:2026-11-17
  • 出版时间:2024-12-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-03-28
  • 修回日期:2024-07-12
基金
作者信息
    濮阳市油田总医院心内科,河南 濮阳 457001
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.12.009
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏